Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis in Post-LASIK Patients
NCT00611403Phase 2Completed
- Sponsor
- Allergan
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine ophthalmic solution in dry eye syndrome (DED), sponsored by Allergan. Started Dec 2007; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00611403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611403.